Liersch, Oliver (Niedersachsen (govt) 200912 State Secretary Ministry of Economic Affairs, Labour and Transport) |
State Secretary |
Niedersachsen (govt region) |
Germany |
Lifton, Richard P. (Roche 201503– Board Member) |
Board member, non-executive |
Roche (Group) |
Switzerland |
Ligner, Emmanuel (General Electric 201812 President + CEO GE Healthcare Life Sciences) |
Chief Executive Officer (CEO) |
General Electric (Group) |
United Kingdom (GB) |
Lillig, John (IRORI Technologies 201311– CEO before Brooks Life Science Systems + Nexus Biosystems) |
Chief Executive Officer (CEO) |
Drug Discovery Partners International |
|
Lim, Riwat (Curetis 2017Q3– Managing Director of Curetis UK Ltd + Commercial Director EMEA before Qiagen) |
Managing Director |
OpGen (Group) |
United Kingdom (GB) |
Lim, Seung-Hak (Daniel) (Seegene 201304 Head Overseas Business division) |
President/Director/Head Business Group/Unit/Division |
Seegene (Group) |
Korea, Republic of |
Lim, Sun Hee (AllMedica 201305 General Manager, Biosensor Research Group) |
General Manager (management) |
AllMedicus Co., Ltd. |
Korea, Republic of |
Limmer, Christian (Constares GmbH 202001 Managing Director) |
n. a. |
Constares GmbH |
Germany |
Limmer, Stefan (Ribopharma) |
n. a. |
LGC (Group) |
Germany |
Lin, He (Shanghai Jiao Tong Univ 201203 Professor + Director of Bio-X Center) |
Professor |
Shanghai Jiao Tong University (SJTU) |
China |
Lin, Raven (I-Mab 201711 Head of Business Development at I-Mab Biopharma) |
Business Development Manager / Strategy Manager |
I-Mab (Group) |
China |
Linari, Marco (Merck (DE) 201409 CEO Allergopharma/Merck Business Unit Allergy) |
Chief Executive Officer (CEO) |
Dermapharm (Group) |
Germany |
Lindauer, Andreas (Synlab 200702) |
n. a. |
Synlab (Group) |
Germany |
Lindemann, Björn F. |
n. a. |
BioAgency AG |
Germany |
Lindemann, Erik P. (BioAgency 201102 CEO) |
Chief Executive Officer (CEO) |
BioAgency AG |
Germany |
Lindemann, Jörg (Wacker 202007 Managing Director of Wacker Biotech BV) |
Managing Director |
Wacker (Group) |
Netherlands |
Lindemann, Michael (bio.logis 2009– Managing Director before IBM before Siemens Medical before Genedata) |
Managing Director |
Genedata (Group) |
Switzerland |
Lindemann, Timo (Sartorius 201906 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
Lindemeier, Jürgen (Xiril 201007 CEO) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
Linden, H. Bernhard (Linden CMS 1979–200910– Managing Director + Founder) |
Managing Director |
Linden ChroMasSpec GmbH (Linden CMS) |
Germany |
Lindenblatt, Hubert (Odgers Berndtson Unternehmensberatung GmbH 201203 Partner) |
Consultant (economic/technology) |
Odgers Berndtson Unternehmensberatung GmbH |
Germany |
Lindenblatt, Jörg (Sartorius 201410 SVP Sales Asia/Pacific) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
Lindhardt, Karsten (Biograil 202001 CEO before Egalet + Novo Nordisk + Ferring + Prosidion + Curalogic) |
n. a. |
Biograil ApS |
Denmark |
Lindhofer, Horst (Lindis Pharma 201004– CEO + Founder before Trion Pharma CEO + Founder) |
Chief Executive Officer (CEO) |
Lindis Biotech GmbH |
Germany |
Lindhorst, Thomas (UgiSense 201604– Exec Board Director + Ugichem 201108 Managing Director CSO + founder) |
Managing Director |
UgiSense AG |
Germany |
Lindhuber, Matthias (Bruker 201703 Bruker AXS GmbH) |
n. a. |
Bruker (Group) |
Germany |
Linding, Rune (Institute of Cancer Research 200907 Head Cellular and Molecular Logic Team) |
Researcher (university / research institute) |
University of London |
United Kingdom (GB) |
Lindinger, Werner (1998–2001+ Prof Univ Innsbruck + CEO + Co-founder Ionicon Analytik GmbH) |
Chief Executive Officer (CEO) |
Ionicon (Group) |
Austria |
Lindner, Wolfgang (Univ Vienna 201402 Professor Emeritus Analytical Chemistry) |
Professor |
University of Vienna (Universität Wien) |
Austria |
Lindpaintner, Klaus (Thermo Fisher 201211– CSO before Strategic Diagnostics + Roche) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Thermo Fisher (Group) |
United States (USA) |
Lingelbach, Dieter (Sirion Biotech 201305 Managing Director (COO) before MorphoSys –200812c Head AbD Serotec) |
Managing Director |
Bio-Rad (Group) |
Germany |
Lingelbach, Thomas (Intercell 201106– CEO before COO before 2001– Chiron Behring) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Austria |
Lingnau, Lutz (Schering) |
n. a. |
Bayer (Group) |
Germany |
Link, Charles J., jr. (NewLink Genetics 201706 CEO) |
Chief Executive Officer (CEO) |
NewLink Genetics Corporation (Nasdaq: NLNK) |
United States (USA) |
Link, Dieter (Max Planck 201104 License Manager at Max Planck Innovation) |
IP Manager |
Max Planck Society for the Advancement of Science |
Germany |
Link, Egenhard (Garching Innovation 200311) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
Link, Markus (Bruker 201503) |
n. a. |
Bruker (Group) |
Germany |
Linnartz, Anke (MorphoSys 201611– Head Corp Communications + IR before Gerresheimer + Demag Cranrd + GEA + MIS) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
Linneberg, Esther (Sividon Diagnsotics GmbH 201202) |
n. a. |
Myriad Genetics (Group) |
Germany |
Linnert, Karoline (Bremen (govt) 201308 Major) |
n. a. |
Bremen (govt region) |
Germany |
Linnertz, Holger (Mettler-Toledo 200712 Head LabX Competence Center) |
Product Manager (personnel) |
Mettler-Toledo (Group) |
Switzerland |
Linnig, Lukas (BRAIN 202010– CFO before Head of Financing, Controlling + Legal joined 201704) |
Chief Financial Officer (CFO) |
BRAIN (Group) |
Germany |
Linscheid, Michael W. (Humboldt Univ Berlin 1009 Professor) |
n. a. |
Humboldt University Berlin |
Germany |
Linseis, Brigitte (Bavaria (govt) 201402 Senior Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
Linsinger, Thomas (EU (govt) 201605 JRC-IRMM Responsible CRM Distriubtion/Scientific Officer) |
n. a. |
EU (govt) |
Belgium |
Linssen, Marcel (Wilex 201309 CBO at Heidelberg Pharma GmbH) |
Chief Business Officer (CBO) |
Heidelberg Pharma (Group) |
Germany |
Linton, William A. (Bill) (Promega 1978– CEO + Founder and Eppendorf 201701– Supervisory Board Member) |
Chief Executive Officer (CEO) |
Promega (Group) |
United States (USA) |
Linz, Fritjof (Sartorius 201903 Head of Separation at SSB) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
Linzbach, Gerold (Symrase 200804 CEO) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Germany |
Lippold, Björn (Chemie.de 201403 Senior Editor) |
Editor / Publisher |
Lumitos (Group) |
Germany |
Lippold, Marcus ([iito] Business Intelligence 2002–) |
Company Founder |
[iito] Business Intelligence |
Germany |
Lipps, Ben (MagForce 201411 CEO) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Germany |
Lipscombe, Richard (Proteomics International 201201 Managing Director) |
Managing Director |
Proteomics International Pty Ltd. |
Australia |
Litchman, Manuel (Mustang Bio 201704– CEO before Arvinas + Novartis Pharmaceuticals Corp) |
Chief Executive Officer (CEO) |
Mustang Bio Inc. (Nasdaq: MBIO) |
United States (USA) |
Litow, Micah (Danaher 201405 Director Reserarch + Innovation Advanced Staining Instruments at Leica Biosystems) |
n. a. |
Danaher (Group) |
Germany |
Little, Melvyn (Affimed 2000–201112 CSO + founder retired 12/11 before DKFZ) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Affimed (Group) |
Germany |
Little, Stephen (Premaitha Health 201512 CEO before Qiagen + DxS) |
Chief Executive Officer (CEO) |
Premaitha Health (Group) |
United Kingdom (GB) |
Little, Tod (Taconic 201309 CEO) |
Chief Executive Officer (CEO) |
Taconic (Group) |
United States (USA) |
Litzka, Olivier (LCF Rothschild 2006–200911– Partner EdRIP before 3i Venture Healthcare) |
Partner (venture partner) |
Andera Partners (FR) |
France |
Liu, Cheng (Eureka Therapeutics 201505 CEO) |
Chief Executive Officer (CEO) |
Eureka Therapeutics Inc. |
United States (USA) |
Liu, Douglas (Qiagen 200507–201710c VP Global Operations before Bayer Healthcare RETIRED 2017) |
n. a. |
Qiagen (Group) |
Netherlands |
Liu, Jack (OmicSoft Corp 201701 President + Co-Founder) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
United States (USA) |
Llewellyn, Chris (Schauenburg 201912 Asia Pacific Sales Manager at Markes 201406 Global Channel Manager) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
Llobet, Manuel (Allergy Therapeutics 201709 CEO) |
Chief Executive Officer (CEO) |
Allergy Therapeutics (Group) |
United Kingdom (GB) |
Lloyd-Harris, Genghis (Abingworth 201402 Partner) |
Partner (venture partner) |
Abingworth (Group) |
United Kingdom (GB) |
Lo, Richard (Techcomp 201411 CEO) |
Chief Executive Officer (CEO) |
Techcomp (Group) |
China |
Loa, Alexander (acCELLerate GmbH 201605 Managing Director) |
Managing Director |
Accellerate GmbH |
Germany |
Lobacki, Joseph (Micromet 201112– COO before Genzyme SVP + General Manager before SangStat Medical + Cell Pathways) |
Chief Operating Officer (COO) |
Amgen (Group) |
United States (USA) |
Lochter, André (atugen 2003– before Nordic Bioscience) |
n. a. |
Silence Therapeutics (Group) |
Germany |
Locker, Susanne (LISAvienna 201310 Project Manager Marketing + PR) |
Sales Manager / Marketing Manager |
Austria (govt) |
Austria |
Lockhoff, Oswald (Sidanis Pharma 201102– Managing Director + Founder before Consultant before Bayer) |
Managing Director |
Sidanis Pharma GmbH |
Germany |
Loeb, Gary H. (Sangamo 201907– EVP + General Counsel before Achaogen + Amyris + Genentech) |
General Counsel / Chief Legal Officer (CLO) |
Sangamo (Group) |
United States (USA) |
Loehr, Achim (CureVac 201710 Head Business Development) |
Business Development Manager / Strategy Manager |
CureVac (Group) |
Germany |
Loescher, Peter (Siemens 200705– CEO before Merck & Co) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
Loew-Friedrich, Iris (UCB 201403 CMO before Schwarz Pharma) |
Chief Medical Officer (CMO) |
UCB (Group) |
Belgium |
Lofton-Day, Catherine (Epigenomics 200607 VP Molecular Biology, Diagnostics) |
n. a. |
Epigenomics (Group) |
Germany |
Lohfink, Martin (up to data 201003 Managing Director) |
Managing Director |
up to data professional services GmbH |
Germany |
Lohmann, Charlotte (MorphoSys 201205– General Counsel before Wilex SVP Legal Affairs + Human Resources before KPMG) |
General Counsel / Chief Legal Officer (CLO) |
MorphoSys (Group) |
Germany |
Lohmann, Christian (Peqlab Biotechnologie 200512) |
n. a. |
Avantor (Group) |
Germany |
Lohmer, Stefan (Axxam 200807 CEO) |
Chief Executive Officer (CEO) |
Axxam S.p.A. |
Italy |
Lohrisch, Hans-Joachim (Altana Pharma 200607 CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Germany |
Lohrmann, Marc (Vesalius Biocapital 202001 Managing Partner at Vesalius Biocapital III) |
Managing Partner (investment firm) |
Vesalius Biocapital (Group) |
Luxembourg |
Lohse, Axel (Germany (govt) 201611 Manager Biotech + Pharma at GTAI) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
Loibner, Hans (Apeiron Biologics 200810–201807 CEO RETIRED 7/18 continues as senior advisor) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
Loiret-Bernal, Cédric (GeneProt 200009 CEO) |
Chief Executive Officer (CEO) |
GeneProt Inc. |
Switzerland |
Longchamp, Pascal (Evolva 201201–201712 CBO TO STEP DOWN unitl end 2017) |
Chief Business Officer (CBO) |
Evolva (Group) |
Switzerland |
Longwell, Lance (Siemens 202104 Director of Communications + PR at Siemens Healthineers) |
Public Relations Manager / Investor Relations Manager |
Siemens (Group) |
Germany |
Looi, Liew Yew (Nycomed 201011 SVP North Asia) |
Regional manager |
Takeda (Group) |
Switzerland |
Loose, Achim (Nordantec GmbH 200902 Managing Director) |
Managing Director |
Nordantec GmbH Norddeutsche Analytik und Messtechnik |
Germany |
Lopata, Michael (Agilent 200809) |
n. a. |
Agilent (Group) |
Germany |
Lopes-Fernandes, Philippe (Ipsen 202010– EVP + CBO based in US before Merck KGaA) |
Chief Business Officer (CBO) |
Ipsen (Group) |
France |
Lopez Belda, Antonio (Biofrontera 201503– Marketing Manager at Biofrontera Spain before Allergan Pharmaceuticals) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Spain (España) |
Lopriore, Stefano (STMicroelectronics 200506) |
n. a. |
STMicroelectronics (Group) |
Switzerland |
Lorenz, Fabian (MC Services 201504– Senior Consultant) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Lorenz, Martin (Platomics 201908 Head of Marketing + Sales) |
Sales Manager / Marketing Manager |
Platomics GmbH |
Austria |
Lorenz, Michael (Univ Bremen + Molzym) |
Managing Director |
Kompass (Group) |
Germany |
Lorenz, Sarah (Univ München 202004 Director Business Development at German Entrepreneurship GmbH) |
Business Development Manager / Strategy Manager |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Los, Georgyi (Leica 200808 Lead Scientist Imaging Products) |
n. a. |
Danaher (Group) |
Germany |
Loss, Christian (Neopharm 201502 Managing Director of Neovii Biotech GmbH) |
Managing Director |
Neopharm (IL) (Group) |
Germany |